BDA
NVO

Borer Denton & Associates’s Novo Nordisk NVO Stock Holding History

Borer Denton & Associates’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.37M Sell
70,247
-3,040
-4% -$131K 1.1% 25
2026
Q1 		$2.69M Sell
73,287
-2,245
-3% -$106K 0.96% 23
2025
Q4 		$3.84M Sell
75,532
-6,687
-8% -$342K 1.3% 20
2025
Q3 		$4.56M Sell
82,219
-22,722
-22% -$1.33M 1.51% 19
2025
Q2 		$7.24M Sell
104,941
-3,392
-3% -$231K 2.51% 18
2025
Q1 		$7.52M Sell
108,333
-4,848
-4% -$400K 2.66% 16
2024
Q4 		$9.74M Sell
113,181
-1,291
-1% -$140K 3.39% 10
2024
Q3 		$13.6M Sell
114,472
-750
-0.7% -$100K 4.65% 6
2024
Q2 		$16.4M Sell
115,222
-800
-0.7% -$106K 5.97% 4
2024
Q1 		$14.9M Sell
116,022
-200
-0.2% -$23.8K 5.27% 4
2023
Q4 		$12M Sell
116,222
-300
-0.3% -$29.7K 4.6% 6
2023
Q3 		$10.6M Sell
116,522
-100
-0.1% -$8.81K 4.38% 6
2023
Q2 		$9.44M Hold
116,622
– – 3.72% 10
2023
Q1 		$9.28M Buy
116,622
+6,970
+6% +$494K 3.85% 10
2022
Q4 		$7.42M Hold
109,652
– – 3.29% 14
2022
Q3 		$5.46M Buy
109,652
+3,580
+3% +$192K 2.72% 17
2022
Q2 		$5.91M Buy
106,072
+150
+0.1% +$8.32K 2.85% 17
2022
Q1 		$5.88M Buy
+105,922
New +$5.44M 2.47% 17

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Borer Denton & Associates's NVO Position: Q2 2026 in Review

Borer Denton & Associates reduced its Novo Nordisk (NVO) stake by 4.1% in Q2 2026, selling an estimated $131K and leaving 70,247 shares worth $3.37M. The position accounts for 1.1% of the portfolio, ranked #25.

Borer Denton & Associates first reported a position in NVO in Q1 2022 and has held it in 18 quarters since. The position peaked at $16.4M in Q2 2024. 1,354 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Borer Denton & Associates held 70,247 shares of Novo Nordisk worth $3.37M as of Q2 2026.
  • Borer Denton & Associates sold 3,040 Novo Nordisk shares in Q2 2026, an estimated $131K.
  • Novo Nordisk made up 1.1% of Borer Denton & Associates's portfolio in Q2 2026, its #25 holding.
  • Borer Denton & Associates first reported a position in Novo Nordisk in Q1 2022 and has held it in 18 quarters since.
  • Borer Denton & Associates's Novo Nordisk position peaked at $16.4M in Q2 2024.
  • 1,354 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Borer Denton & Associates's 13F filing for Q2 2026, filed 28 Jul 2026.